Search results
Mayo Clinic expert answers common questions about the flu, COVID-19. Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life.
15 wrz 2022 · Despite the many advances in cardiovascular medicine, decisions concerning the diagnosis, prevention, and treatment of left ventricular (LV) thrombus often remain challenging. There are only limited organizational guideline recommendations with regard to LV thrombus.
Etiology and Treatment of LV Thrombus. Cumulative etiologies (A) and long-term anticoagulants (B) selected for treatment of left ventricular (LV) thrombus. In-hospital mortality was 7.8%. An additional 7.8% were not initiated on long-term anticoagulation due to medical contraindications.
4 lip 2023 · It is vital to treat mural thrombi as this can lower the risk of stroke, myocardial infarction, and pulmonary embolism. There are no standardized guidelines for the treatment of mural thrombi. The type of treatment depends on the location of thrombi, patient symptoms, and urgency of the situation.
23 wrz 2022 · On the basis of limited data, patients with nonischemic cardiomyopathy with LV thrombus should be treated with OAC for at least 3–6 months, with discontinuation if LV ejection fraction improves to >35% (assuming resolution of the LV thrombus) or if major bleeding occurs.
The purpose of this study was to quantify the effect of anticoagulation therapy on LVT evolution using sequential imaging and to determine the impact of LVT regression on the incidence of thromboembolism, bleeding, and mortality.
7 kwi 2020 · The authors identified 159 patients with confirmed LV thrombus. These patients were treated with vitamin K antagonists (48.4%), parenteral heparin (27.7%), or direct oral anticoagulants (22.6%). Antiplatelet therapy was used in 67.9% of cases.
